Osteonecrosis due to drugs, other site
ICD-10 M87.18 is a billable code used to indicate a diagnosis of osteonecrosis due to drugs, other site.
Osteonecrosis, also known as avascular necrosis, is a condition characterized by the death of bone tissue due to a lack of blood supply. This specific code, M87.18, refers to osteonecrosis that occurs as a result of drug use, affecting sites other than the hip or knee. Commonly implicated drugs include corticosteroids and bisphosphonates, which can disrupt the normal blood flow to bones. Patients may present with pain, swelling, and limited range of motion in the affected area. The condition can lead to severe complications, including joint collapse and the need for surgical interventions such as joint replacement. Diagnosis typically involves imaging studies like MRI or X-rays, which can reveal changes in bone density and structure. Treatment options may vary from conservative management, including pain relief and physical therapy, to more invasive procedures depending on the severity of the condition. Understanding the implications of drug-induced osteonecrosis is crucial for effective management and coding, as it can significantly impact patient outcomes and healthcare costs.
Detailed history of medication use, imaging results, and clinical findings.
Patients presenting with joint pain after corticosteroid therapy or bisphosphonate treatment.
Orthopedic surgeons should ensure that the site of osteonecrosis is clearly documented to avoid coding errors.
Comprehensive medication history, including duration and dosage of drugs that may contribute to osteonecrosis.
Patients with autoimmune diseases on long-term corticosteroids presenting with joint symptoms.
Rheumatologists should be aware of the potential for drug-induced osteonecrosis in patients receiving immunosuppressive therapy.
Used for pain management in patients with osteonecrosis.
Document the indication for the procedure and the joint involved.
Orthopedic specialists should ensure that the procedure is linked to the diagnosis of osteonecrosis.
Common drugs associated with osteonecrosis include corticosteroids, bisphosphonates, and certain chemotherapy agents. It is important to document the specific medications and dosages used by the patient.
